The Pediatric Brain Tumor Consortium (PBTC) was formed by the National Cancer Institute (NCI) in 1999 to improve the treatment of primary brain tumors in children. The participating academic centers and children's hospitals are responsible for the diagnosis and treatment of a large percentage of children with primary brain tumors in the United States. Learn more »
Years since inception: 21
Patients enrolled: 1890
Active therapeutic studies: 9
Completed therapeutic studies: 38
Non-therapeutic studies activated: 10
Participating sites: CAChildren’s Hospital Los Angeles, CALucile Packard Children's Hospital Stanford, COChildren's Hospital Colorado, DCChildren’s National Medical Center (Washington, DC), GAChildren's Healthcare of Atlanta, ILAnn & Robert H. Lurie Children’s Hospital of Chicago, MDNIH-Pediatric Oncology Branch, NYMemorial Sloan Kettering Cancer Center, OHCincinnati Children's Hospital Medical Center, PAChildren’s Hospital of Pittsburgh, TNSt. Jude Children’s Research Hospital, TXTexas Children's Cancer Center.